Is Kintara Therapeutics A Hidden Gem?
The stock has fallen since last year but rebounding.Earnings are negative, but analysts expect impressive positive, long-term growth.Recent product developments support long-term growth expectations.5 stocks we like better than Kintara TherapeuticsAt first glance, it might seem likeKintara Therapeutics Inc (NASDAQ:KTRA) would not be a good investment. After all, analysts gave the stock a HOLD rating after its Q3 earnings report in November. However, that rating alone is not enough to understand the full scope of possibility in its future, which suggest big things to come. Q3 2022 hedge fund le...